BDX - BECTON DICKINSON & CO


205.08
0.630   0.307%

Share volume: 1,690,557
Last Updated: 04-25-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%

$204.45
0.63
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
52%
Profitability 45%
Dept financing 50%
Liquidity 57%
Performance 59%
Company vs Stock growth
vs
Performance
5 Days
2.60%
1 Month
-10.33%
3 Months
-17.54%
6 Months
-14.16%
1 Year
-12.15%
2 Year
-22.11%
Key data
Stock price
$205.08
P/E Ratio 
37.98
DAY RANGE
$201.99 - $205.38
EPS 
$5.96
52 WEEK RANGE
$193.03 - $251.98
52 WEEK CHANGE
-$12.15
MARKET CAP 
65.593 B
YIELD 
1.71%
SHARES OUTSTANDING 
289.042 M
DIVIDEND
$1.04
EX-DIVIDEND DATE
03-10-2025
NEXT EARNINGS DATE
N/A
BETA 
0.18
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,384,288
AVERAGE 30 VOLUME 
$2,544,702
Company detail
CEO: Thomas E. Polen
Region: US
Website: bd.com
Employees: 77,000
IPO year: 1983
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis cathetters, vascular care and preparation products, needle-free IV connectors and extensions sets, syringes, pen needles, and other products for diabetes. Its Life Sciences segment provides specimen and blood collection products; other surgical products.

Recent news
loading